Table 1 (a) The mean ± SD values of 15 MSLQ-J categories. (b) Distribution of PIE-J stages in Group A and Group B

MSLQ

Group

Baseline

PBL1

PBL2

PBL3

PBL4

PBL5

PBL6

IGO

A

3.76 ± 1.05

3.84 ± 1.27

3.90 ± 1.29

4.15 ± 1.35

4.04 ± 1.49

4.17 ± 1.46

4.12 ± 0.99

B

4.10 ± 1.25

4.23 ± 1.00

4.12 ± 1.33

4.15 ± 1.17

4.22 ± 1.27

4.34 ± 1.64

4.34 ± 1.25

EGO

A

3.34 ± 1.29

3.48 ± 1.33

3.63 ± 1.43

3.75 ± 1.43

3.66 ± 1.56

3.54 ± 1.53

3.84 ± 1.38

B

3.68 ± 1.32

3.69 ± 1.15

3.82 ± 1.34

3.94 ± 1.30

3.91 ± 1.41

3.94 ± 1.62

3.81 ± 1.43

TV

A

4.99 ± 0.91

4.64 ± 1.41

4.48 ± 1.38

4.74 ± 1.54

4.59 ± 1.58

4.56 ± 1.65

4.74 ± 1.10

B

4.95 ± 0.97

4.91 ± 0.93

4.49 ± 1.29

4.74 ± 1.33

4.64 ± 1.44

4.59 ± 1.77

4.90 ± 1.31

CBaL

A

4.57 ± 0.93

4.41 ± 1.21

4.21 ± 1.18

4.33 ± 1.32

4.21 ± 1.44

4.22 ± 1.53

4.47 ± 1.00

B

4.63 ± 0.99

4.64 ± 0.83

4.27 ± 1.27

4.43 ± 1.21

4.41 ± 1.30

4.37 ± 1.59

4.60 ± 1.20

SEfLaP

A

3.00 ± 1.19

3.42 ± 1.37

3.51 ± 1.26

3.64 ± 1.34

3.66 ± 1.46

3.92 ± 1.56

3.75 ± 1.17

B

3.24 ± 1.16

3.68 ± 0.96

3.90 ± 1.33

4.07 ± 1.16

4.03 ± 1.26

4.03 ± 1.50

3.94 ± 1.19

TA

A

4.09 ± 1.24

4.06 ± 1.28

4.10 ± 1.43

4.15 ± 1.41

4.10 ± 1.60

3.94 ± 1.59

4.13 ± 1.30

B

3.79 ± 1.26

3.90 ± 1.05

3.83 ± 1.28

4.03 ± 1.15

3.75 ± 1.30

3.83 ± 1.51

3.99 ± 1.27

R

A

3.93 ± 0.90

4.19 ± 1.20

4.20 ± 1.22

4.19 ± 1.32

4.10 ± 1.43

4.17 ± 1.45

4.21 ± 1.03

B

3.79 ± 1.12

4.13 ± 0.86

4.15 ± 1.25

4.05 ± 1.16

4.12 ± 1.21

4.42 ± 1.64

4.37 ± 1.14

ELA

A

4.72 ± 0.90

4.47 ± 1.19

4.39 ± 1.20

4.55 ± 1.40

4.48 ± 1.54

4.41 ± 1.56

4.57 ± 1.06

B

4.59 ± 1.14

4.54 ± 0.90

4.44 ± 1.33

4.40 ± 1.22

4.35 ± 1.38

4.38 ± 1.66

4.60 ± 1.22

O

A

4.18 ± 1.26

4.31 ± 1.34

4.34 ± 1.37

4.46 ± 1.51

4.42 ± 1.57

4.41 ± 1.60

4.40 ± 1.14

B

4.09 ± 1.14

4.21 ± 1.02

4.38 ± 1.32

4.33 ± 1.34

4.20 ± 1.35

4.22 ± 1.61

4.44 ± 1.28

CT

A

4.15 ± 0.85

4.28 ± 1.14

4.29 ± 1.27

4.18 ± 1.32

4.20 ± 1.51

4.22 ± 1.47

4.26 ± 0.88

B

4.14 ± 1.08

4.20 ± 0.76

4.22 ± 1.27

4.09 ± 1.23

4.12 ± 1.22

4.14 ± 1.57

4.36 ± 1.15

MSR

A

4.06 ± 0.62

4.22 ± 0.99

4.26 ± 1.06

4.24 ± 1.17

4.25 ± 1.31

4.27 ± 1.34

4.28 ± 0.65

B

4.03 ± 0.77

4.19 ± 0.55

4.16 ± 1.12

4.16 ± 0.95

4.15 ± 1.12

4.20 ± 1.43

4.33 ± 0.98

TaSE

A

4.25 ± 0.74

4.23 ± 0.99

4.21 ± 1.00

4.46 ± 1.18

4.28 ± 1.28

4.29 ± 1.36

4.37 ± 0.63

B

4.15 ± 0.77

4.28 ± 0.66

4.32 ± 1.13

4.22 ± 0.98

4.06 ± 1.12

4.33 ± 1.46

4.38 ± 1.01

ER

A

4.50 ± 0.89

4.46 ± 1.17

4.21 ± 1.07

4.38 ± 1.20

4.31 ± 1.35

4.32 ± 1.41

4.31 ± 0.63

B

4.28 ± 0.91

4.49 ± 0.81

4.26 ± 1.22

4.21 ± 1.11

4.14 ± 1.20

4.31 ± 1.51

4.29 ± 1.10

PL

A

4.51 ± 1.05

4.33 ± 1.38

4.27 ± 1.32

4.44 ± 1.53

4.33 ± 1.60

4.36 ± 1.65

4.40 ± 1.09

B

4.56 ± 1.27

4.64 ± 0.94

4.38 ± 1.42

4.37 ± 1.32

4.30 ± 1.43

4.25 ± 1.73

4.50 ± 1.32

HS

A

4.46 ± 0.93

4.36 ± 1.23

4.23 ± 1.16

4.32 ± 1.25

4.25 ± 1.40

4.34 ± 1.54

4.29 ± 0.82

B

4.58 ± 0.77

4.42 ± 0.71

4.25 ± 1.21

4.21 ± 1.16

4.18 ± 1.21

4.39 ± 1.53

4.31 ± 1.10

PIE-J stagesI

PIE1

PIE2

PIE3

PIE1

PIE2

PIE3

II

7

2

2

6

5

1

II/III

21

14

15

28

18

15

III

22

20

10

16

26

18

III/IV

4

13

19

4

3

13

IV

0

0

8

0

1

3

IV/V

0

0

0

0

0

0

V

0

0

0

0

0

0